Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
MARKER THERAPEUTICS, INC. (MRKR) Debt to Equity Ratio data is not available for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$1.10M |
|
$-1.70M |
|
-- |
|
$1.10M |
|
$2.99M |
|
$-1.88M |
|
$0.17M |
|
$-1.72M |
|
$-1.72M |
|
$-1.70M |
|
$-1.70M |
|
$-1.70M |
|
$-1.70M |
|
$-1.88M |
|
$-1.88M |
|
15.31M |
|
15.31M |
|
$0.02 |
|
$0.02 |
|
| Balance Sheet Financials | |
$19.07M |
|
-- |
|
-- |
|
$19.07M |
|
$2.27M |
|
-- |
|
-- |
|
$2.27M |
|
$16.80M |
|
$16.80M |
|
$16.80M |
|
16.70M |
|
| Cash Flow Statement Financials | |
$-12.01M |
|
-- |
|
$9.86M |
|
$19.19M |
|
$17.04M |
|
$-2.15M |
|
$0.54M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.39 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
100.00% |
|
-170.74% |
|
-170.74% |
|
-- |
|
-155.73% |
|
-154.35% |
|
$-12.01M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
-- |
|
0.81 |
|
111.69 |
|
-10.14% |
|
-10.14% |
|
-8.93% |
|
-10.14% |
|
$1.01 |
|
$-0.78 |
|
$-0.78 |
|